The store will not work correctly when cookies are disabled.
2-(5-Methyl-1H-[1,2,4]triazol-3-yl)-3-(3-nitro-phenyl)-acrylonitrile
ID: ALA117701
PubChem CID: 11311376
Max Phase: Preclinical
Molecular Formula: C12H9N5O2
Molecular Weight: 255.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1n[nH]c(/C(C#N)=C/c2cccc([N+](=O)[O-])c2)n1
Standard InChI: InChI=1S/C12H9N5O2/c1-8-14-12(16-15-8)10(7-13)5-9-3-2-4-11(6-9)17(18)19/h2-6H,1H3,(H,14,15,16)/b10-5+
Standard InChI Key: RPFSRBISWZFZMC-BJMVGYQFSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-2.1000 -0.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5125 -0.8042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2750 -0.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8000 -1.8917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6583 0.5250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4000 0.1958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3208 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8000 -0.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9250 0.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3250 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5750 1.4875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4542 -2.6417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6250 -1.8167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0250 -0.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5000 -1.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6667 -0.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9375 -1.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1875 0.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3667 0.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 10 1 0
5 1 1 0
6 5 1 0
7 2 1 0
8 3 2 0
9 3 1 0
10 15 2 0
11 9 3 0
12 4 1 0
13 4 2 0
14 8 1 0
15 14 1 0
16 18 2 0
17 7 1 0
18 19 1 0
19 14 2 0
6 7 2 0
10 16 1 0
M CHG 2 4 1 12 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.24 | Molecular Weight (Monoisotopic): 255.0756 | AlogP: 2.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 108.50 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.44 | CX Basic pKa: 0.86 | CX LogP: 2.88 | CX LogD: 2.87 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.51 | Np Likeness Score: -2.03 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |